We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

SEC Filings

Form 6-K
AC IMMUNE SA filed this Form 6-K on 10/13/2016
Document Outline
Entire Document (913.8 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - SIGNATURE
Page 3 - EXHIBIT INDEX
Subdocument 2 - EX-99.1 - EXHIBIT 99.1
Page 1 - Exhibit 99.1
Page 2 - Agenda Items and Proposals of the Board of Directors
Page 3 - i
Page 4 - N/A
Page 5 - Organizational Matters
Subdocument 3 - EX-99.2 - EXHIBIT 99.2
Page 1 - Exhibit 99.2
Subdocument 4 - EX-99.3 - EXHIBIT 99.3
Page 1 - Exhibit 99.3
Page 2 - IF YOU HAVE NOT VOTED VIA THE INTERNET, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM POR
Subdocument 5 - EX-99.4 - EXHIBIT 99.4
Page 1 - Exhibit 99.4
Page 2 - AC Immune SA, Ecublens
Page 3 - Income Statement
Page 4 - Notes to the financial statements
Page 5 - Current vs. non-current classification
Page 6 - Grant revenue
Page 7 - Cash and cash equivalents
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Subdocument 6 - EX-99.5 - EXHIBIT 99.5
Page 1 - Exhibit 99.5
Page 2 - Enclosures
Subdocument 7 - EX-99.6 - EXHIBIT 99.6
Page 1 - Exhibit 99.6
Page 2 - N/A
Page 3 - For the Years Ended December 31,
Page 4 - N/A
Page 5 - N/A
Page 6 - Going concern
Page 7 - Basis of measurement
Page 8 - Milestone payments
Page 9 - Financial assets liabilities
Page 10 - Employee benefits
Page 11 - Taxation
Page 12 - Segment reporting
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - Increase of Conditional Capital
Page 17 - Current portion of deferred income
Page 18 - Anti-tau antibody in AD Collaboration agreement of 2012 with Genentech
Page 19 - Tau-PET imaging agent in AD Collaboration agreement of 2014 with Piramal Imaging
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - A. Change in defined benefit obligation
Page 24 - C. Change in net defined benefit liability
Page 25 - N/A
Page 26 - Foreign currency
Page 27 - Foreign exchange risk
Page 28 - Notes to the Financial Statements (IFRS) (in CHF thousands)
Subdocument 8 - EX-99.7 - EXHIBIT 99.7
Page 1 - Exhibit 99.7
Subdocument 9 - EX-99.8 - EXHIBIT 99.8
Page 1 - Exhibit 99.8
Page 2 - Fair Market Value
Page 3 - Performance Cycle
Page 4 - Stock
Page 5 - Delegation of Authority to Grant Awards
Page 6 - Ordonnance contre les r mun rations abusives dans les soci t s anonymes cot es en bourse
Page 7 - Changes in Stock
Page 8 - Award of Stock Options
Page 9 - Method of Exercise
Page 10 - Exercise Price of Stock Appreciation Rights
Page 11 - Vesting of Restricted Shares
Page 12 - Grant or Sale of Unrestricted Stock
Page 13 - Grant of Performance-Based Awards
Page 14 - Transferability
Page 15 - Payment in Stock
Page 16 - No Distribution
Page 17 - GOVERNING LAW AND JURISDICTION